HINOON Pharmaceuticals: Major
Health Technology
Mkt Cap
51.2B
P/E (TTM)
12.77
EPS
77.92
ROE
29.09%
Div Yield
5.18%
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Return on Equity (ROE) | 32.32% | 31.04% | 27.67% | 36.44% | 35.33% | |
| Return on Assets (ROA) | 22.18% | 20.88% | 18.72% | 25.20% | 23.89% | |
| Return on Invested Capital | 31.37% | 29.31% | 26.05% | 35.60% | 33.96% | |
| Gross Margin | 52.94% | 49.23% | 46.06% | 50.08% | 48.59% | |
| Operating Margin | 23.02% | 20.43% | 17.36% | 20.57% | 18.12% | |
| EBITDA Margin | 24.58% | 21.88% | 18.74% | 21.95% | 19.63% | |
| Net Margin | 14.90% | 13.75% | 12.38% | 15.63% | 14.28% | |
| Pre-Tax Margin | 23.79% | 20.34% | 16.91% | 21.78% | 18.74% | |
| Liquidity | ||||||
| Current Ratio | 3.03 | 3.02 | 3.43 | 3.31 | 3.59 | |
| Quick Ratio | 1.76 | 1.84 | 1.73 | 1.58 | 2.18 | |
| Leverage | ||||||
| Debt / Equity | 0.06 | 0.12 | 0.15 | 0.10 | 0.06 | |
| Debt / Assets | 0.04 | 0.08 | 0.10 | 0.07 | 0.04 | |
| LT Debt / Equity | 0.03 | 0.03 | 0.09 | 0.03 | 0.02 | |
| LT Debt / Assets | 0.02 | 0.02 | 0.06 | 0.02 | 0.01 | |
| Net Debt | -2.87B | -3.80B | -994.52M | -1.19B | -2.65B | |
| Total Debt | 801.70M | 1.37B | 1.50B | 787.83M | 374.74M | |
| Efficiency | ||||||
| Asset Turnover | 1.49 | 1.52 | 1.51 | 1.61 | 1.67 | |
| Inventory Turnover | 2.29 | 2.42 | 2.21 | 2.27 | 2.76 | |
| Per Share | ||||||
| Book Value Per Share | 259.57 | 222.62 | 189.41 | 144.48 | 111.68 | |
| Tangible Book Per Share | 258.84 | 221.72 | 188.79 | 143.79 | 111.25 | |
| Cash Per Share | 69.35 | 97.50 | 47.14 | 37.39 | 57.07 | |
| Total Debt Per Share | 15.13 | 25.82 | 28.37 | 14.87 | 7.07 | |
| Working Capital Per Share | 187.86 | 166.34 | 141.01 | 111.12 | 87.85 | |
| Shares & Market | ||||||
| Total Shares Outstanding | 52,983,363 | 52,983,363 | 52,983,363 | 52,983,372 | 52,983,368 | |
| Market Cap | 54.17B | 48.65B | 26.73B | 22.62B | 23.91B | |
| Enterprise Value | 51.30B | 44.85B | 25.74B | 21.43B | 21.26B | |
| Employees | 2,563 | 2,376 | 2,396 | 2,382 | 2,315 | |
| Shareholders | 5,558 | 5,558 | 5,558 | 5,558 | 5,558 | |